Dr. Mark Landy, director of research for medical technology and regenerative medicine at Summer Street Research Partners, has spent 17 years on Wall Street and in the medical device industry, and has significant transactional experience in both the developed and emerging markets. Dr. Landy has been recognized in numerous Institutional Investor magazine Top Analyst Polls, and was named to the "2008 PharmaVOICE 100″ list of the top 100 inspirational people in the life science industry. Dr. Landy graduated from University of the Witwatersrand, Johannesburg, South Africa, and worked as a dental surgeon in South Africa and the United Kingdom before studying finance and management at the Wharton School of Business.
"RP is at the forefront of the utilization of stem cells to treat disorders and defects."
The Life Sciences Report Interview with Mark Landy
"EXAC's Q2/14 revenues of $63.9M (+5%) were above our forecast."
Mark Landy, Summer Street Research Partners